Literature DB >> 19625255

Binding and cleavage specificities of human Argonaute2.

Walt F Lima1, Hongjiang Wu, Josh G Nichols, Hong Sun, Heather M Murray, Stanley T Crooke.   

Abstract

The endonuclease Argonaute2 (Ago2) mediates the degradation of the target mRNA within the RNA-induced silencing complex. We determined the binding and cleavage properties of recombinant human Ago2. Human Ago2 was unable to cleave preformed RNA duplexes and exhibited weaker binding affinity for RNA duplexes compared with the single strand RNA. The enzyme exhibited greater RNase H activity in the presence of Mn2+ compared with Mg2+. Human Ago2 exhibited weaker binding affinities and reduced cleavage activities for antisense RNAs with either a 5'-terminal hydroxyl or abasic nucleotide. Binding kinetics suggest that the 5'-terminal heterocycle base nucleates the interaction between the enzyme and the antisense RNA, and the 5'-phosphate stabilizes the interaction. Mn2+ ameliorated the effects of the 5'-terminal hydroxyl or abasic nucleotide on Ago2 cleavage activity and binding affinity. Nucleotide substitutions at the 3' terminus of the antisense RNA had no effect on human Ago2 cleavage activity, whereas 2'-methoxyethyl substitutions at position 2 reduced binding and cleavage activity and 12-14 reduced the cleavage activity. RNase protection assays indicated that human Ago2 interacts with the first 14 nucleotides at the 5'-pole of the antisense RNA. Human Ago2 preloaded with the antisense RNA exhibited greater binding affinities for longer sense RNAs suggesting that the enzyme interacts with regions in the sense RNA outside the site for antisense hybridization. Finally, transiently expressed human Ago2 immunoprecipitated from HeLa cells contained the double strand RNA-binding protein human immunodeficiency virus, type 1, trans-activating response RNA-binding protein, and deletion mutants of Ago2 showed that trans-activating response RNA-binding protein interacts with the PIWI domain of the enzyme.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19625255      PMCID: PMC2758002          DOI: 10.1074/jbc.M109.010835

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  39 in total

1.  RNA interference is mediated by 21- and 22-nucleotide RNAs.

Authors:  S M Elbashir; W Lendeckel; T Tuschl
Journal:  Genes Dev       Date:  2001-01-15       Impact factor: 11.361

Review 2.  Post-transcriptional gene silencing by double-stranded RNA.

Authors:  S M Hammond; A A Caudy; G J Hannon
Journal:  Nat Rev Genet       Date:  2001-02       Impact factor: 53.242

3.  An RNA-directed nuclease mediates post-transcriptional gene silencing in Drosophila cells.

Authors:  S M Hammond; E Bernstein; D Beach; G J Hannon
Journal:  Nature       Date:  2000-03-16       Impact factor: 49.962

4.  ATP requirements and small interfering RNA structure in the RNA interference pathway.

Authors:  A Nykänen; B Haley; P D Zamore
Journal:  Cell       Date:  2001-11-02       Impact factor: 41.582

5.  A cellular function for the RNA-interference enzyme Dicer in the maturation of the let-7 small temporal RNA.

Authors:  G Hutvágner; J McLachlan; A E Pasquinelli; E Bálint; T Tuschl; P D Zamore
Journal:  Science       Date:  2001-07-12       Impact factor: 47.728

6.  Dicer functions in RNA interference and in synthesis of small RNA involved in developmental timing in C. elegans.

Authors:  R F Ketting; S E Fischer; E Bernstein; T Sijen; G J Hannon; R H Plasterk
Journal:  Genes Dev       Date:  2001-10-15       Impact factor: 11.361

7.  Role for a bidentate ribonuclease in the initiation step of RNA interference.

Authors:  E Bernstein; A A Caudy; S M Hammond; G J Hannon
Journal:  Nature       Date:  2001-01-18       Impact factor: 49.962

8.  Genes and mechanisms related to RNA interference regulate expression of the small temporal RNAs that control C. elegans developmental timing.

Authors:  A Grishok; A E Pasquinelli; D Conte; N Li; S Parrish; I Ha; D L Baillie; A Fire; G Ruvkun; C C Mello
Journal:  Cell       Date:  2001-07-13       Impact factor: 41.582

9.  Co-crystal of Escherichia coli RNase HI with Mn2+ ions reveals two divalent metals bound in the active site.

Authors:  E R Goedken; S Marqusee
Journal:  J Biol Chem       Date:  2000-11-16       Impact factor: 5.157

10.  Human Dicer binds short single-strand and double-strand RNA with high affinity and interacts with different regions of the nucleic acids.

Authors:  Walt F Lima; Heather Murray; Josh G Nichols; Hongjiang Wu; Hong Sun; Thazha P Prakash; Andres R Berdeja; Hans J Gaus; Stanley T Crooke
Journal:  J Biol Chem       Date:  2008-11-18       Impact factor: 5.157

View more
  48 in total

1.  Exogenous plant MIR168a specifically targets mammalian LDLRAP1: evidence of cross-kingdom regulation by microRNA.

Authors:  Lin Zhang; Dongxia Hou; Xi Chen; Donghai Li; Lingyun Zhu; Yujing Zhang; Jing Li; Zhen Bian; Xiangying Liang; Xing Cai; Yuan Yin; Cheng Wang; Tianfu Zhang; Dihan Zhu; Dianmu Zhang; Jie Xu; Qun Chen; Yi Ba; Jing Liu; Qiang Wang; Jianqun Chen; Jin Wang; Meng Wang; Qipeng Zhang; Junfeng Zhang; Ke Zen; Chen-Yu Zhang
Journal:  Cell Res       Date:  2011-09-20       Impact factor: 25.617

2.  Minor-groove-modulating adenosine replacements control protein binding and RNAi activity in siRNAs.

Authors:  Hayden Peacock; Erik Fostvedt; Peter A Beal
Journal:  ACS Chem Biol       Date:  2010-10-07       Impact factor: 5.100

3.  Thermodynamic basis of selectivity in guide-target-mismatched RNA interference.

Authors:  Thomas T Joseph; Roman Osman
Journal:  Proteins       Date:  2012-02-10

Review 4.  Chemical modification of siRNA bases to probe and enhance RNA interference.

Authors:  Hayden Peacock; Arunkumar Kannan; Peter A Beal; Cynthia J Burrows
Journal:  J Org Chem       Date:  2011-08-17       Impact factor: 4.354

5.  Unraveling regulation and new components of human P-bodies through a protein interaction framework and experimental validation.

Authors:  Dinghai Zheng; Chyi-Ying A Chen; Ann-Bin Shyu
Journal:  RNA       Date:  2011-07-12       Impact factor: 4.942

6.  Human nuclear ARGONAUTE 2 interacts in vivo only with small RNAs and not with DNA.

Authors:  Ubaldo Gioia; Fabrizio d'Adda di Fagagna
Journal:  Cell Cycle       Date:  2015-05-13       Impact factor: 4.534

7.  Antisense correction of SMN2 splicing in the CNS rescues necrosis in a type III SMA mouse model.

Authors:  Yimin Hua; Kentaro Sahashi; Gene Hung; Frank Rigo; Marco A Passini; C Frank Bennett; Adrian R Krainer
Journal:  Genes Dev       Date:  2010-07-12       Impact factor: 11.361

8.  Modified dsRNAs that are not processed by Dicer maintain potency and are incorporated into the RISC.

Authors:  William Salomon; Karen Bulock; Jennifer Lapierre; Pamela Pavco; Tod Woolf; Joanne Kamens
Journal:  Nucleic Acids Res       Date:  2010-02-18       Impact factor: 16.971

9.  Involvement of argonaute proteins in gene silencing and activation by RNAs complementary to a non-coding transcript at the progesterone receptor promoter.

Authors:  Yongjun Chu; Xuan Yue; Scott T Younger; Bethany A Janowski; David R Corey
Journal:  Nucleic Acids Res       Date:  2010-07-30       Impact factor: 16.971

10.  Analysis of acyclic nucleoside modifications in siRNAs finds sensitivity at position 1 that is restored by 5'-terminal phosphorylation both in vitro and in vivo.

Authors:  Denise M Kenski; Abby J Cooper; Jenny J Li; Aarron T Willingham; Henry J Haringsma; Tracy A Young; Nelly A Kuklin; Jeffrey J Jones; Mark T Cancilla; Daniel R McMasters; Melina Mathur; Alan B Sachs; W Michael Flanagan
Journal:  Nucleic Acids Res       Date:  2009-11-16       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.